Resumen La fibrinólisis intravenosa con activador del plasminógeno tisular recombinante (rTPA) y la utilización de unidades cerradas, demostraron disminuir sustancialmente la morbimortalidad en pacientes con accidente cerebrovascular isquémico (ACVi). Sin embargo, los datos publicados en Argentina so...
We report a 78-year-old man with a basal Rankin score of 2 points, last seen 10 hours before in good conditions, who arrived at the emergency department with left hemiparesis, hypoesthesia, and spacial neglect. Neuroimaging was compatible with stroke in the territory of the right middle cerebral artery. ...
OBJECTIVES: To investigate the safety and efficacy of combined tirofiban-ozagrel therapy for treating progressive stroke patients out of thrombolytic therapy time window. METHODS: This prospective, double-blind, randomized controlled study included 337 patients who had experienced an acute ischemic stro...
Enfermedad de Moyamoya/diagnóstico por imagen,
Cardiomiopatía Hipertrófica/diagnóstico por imagen,
Accidente Cerebrovascular/complicaciones,
Accidente Cerebrovascular/tratamiento farmacológico,
Tomografía Computarizada por Rayos X/métodos,
Electrocardiografía,
Ecocardiografía Doppler en Color,
Anticoagulantes/farmacología,
Valsartán/farmacología,
Fibrilación Atrial/complicaciones,
Embolia Intracraneal/etiología,
Terapia Antiplaquetaria Doble/métodos,
Inhibidores de Hidroximetilglutaril-CoA Reductasas/farmacología,
Enfermedad de Moyamoya/terapia
This study aimed to explore the effect of intravenous thrombolysis with alteplase on clinical efficacy, inflammatory factors, and neurological function in patients with acute cerebral infarction. A total of 120 patients with acute cerebral infarction were divided into two groups by the random number tabl...
Abstract Background: Low-dose alteplase (LrtPA) has been shown not to be inferior to the standard-dose (SrtPA) with respect to death/disability. Objective: We aim to evaluate the percentage of patients treated with LrtPA at our center after the ENCHANTED trial and the factors associated with the use of...
ABSTRACT Background: Statin therapy has become one of the most important advances in stroke secondary prevention. Objective: To provide evidence from real-world data for evaluating detailed associations between secondary prevention of stroke and statin use in Brazil. Methods: We conducted a prospec...
Brunser, Alejandro M.;
Mazzon, Enrico;
Muñoz, Paula;
Hoppe, Arnold;
Lavados, Pablo M.;
Rojo, Alexis;
Navia, Víctor;
Cavada, Gabriel;
Olavarría, Verónica V.;
Mansilla, Eloy.
Background: Intravenous thrombolysis (IT) in acute ischemic stroke (AIS) is time dependent. The time elapsed from hospital admission to the thrombolytic bolus is named door to needle time (DNT) and is recommend to be of less than 60 min. Aim: To describe the DNT in our center and determine those factors ...
Furlan, Natalia Eduarda;
Souza, Juli Thomaz de;
Bazan, Silméia Garcia Zanati;
Franco, Roberto Jorge da Silva;
Luvizutto, Gustavo José;
Gut, Ana Lúcia;
Modolo, Gabriel Pinheiro;
Winckler, Fernanda Cristina;
Martin, Luis Cuadrado;
Bazan, Rodrigo.
Abstract Ischemic stroke is a common cause of death. The role of statins in the secondary prevention of the chronic ischemic stroke phase has been established. However, evidence regarding their efficacy in this phase is limited and contradictory. Objective: To evaluate the association between statin us...
This study aimed to investigate whether the routine administration of escitalopram for three months would improve the prognosis of patients with ischemic stroke and decrease the plasma copeptin level. A total of 97 patients with acute cerebral infarction were randomly allocated to receive escitalopram (5...
